Individualized targeted therapy: Using new methods of molecular analysis, to help doctors and patients choose the most effective drugs, and to better control the disease progression according to the patient's genetic characteristics, thus to develop a suitable personalized therapy.
EGFR is a transmembrane receptor tyrosine kinase, which could be activated by anto phosphorylation upon ligand binding, the activation of EGFR contributes to promote cancer cell proliferation and relevant signal transduction significantly.The status of EGFR gene mutation is the most important factor for predicting EGFR-TKI efficacy, which is the prerequisite for determining whether the EGFR-TKI therapy is suitable for the specific patients.
Personalized medicine selectionguidance: A detection result can help the doctors select suitable target drugsand assist the doctors make the judgement about the EGFR-TKI resistance/sensitivity.
Stable and Reliable:Closed tube detection, avoid contamination.
High Sensitivity: The detection can reach as low as 1%in 10 ng DNA.
Easy Operation: One step operation, only 90 minutesto finish the detection.
Good Reproducibility:Can be performed in the general PCR Labs. Results with good reproducibility canbe easily obtained without special training.
Advanced Technology: R&D based on independent patented PAP-ARMS® technology.